MedPath

DONNATAL ELIXIR

DONNATAL ELIXIR

Discontinued
DIN Number

02042894

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

wyeth-ayerst canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02042894
AIG Number0404677001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA IV)
A
ATC Code
A03ED ANTISPASMODICS IN COMBINATION WITH OTHER DRUGS
Product Specifications
Dosage FormElixir
Route of AdministrationOral
AHFS Classification12:08.08
Health Canada Classification

ACTIVE INGREDIENTS (4)

ATROPINE SULFATEActive
Strength: 0.0194 MG / 5 ML
Monograph: ATROPINE SULFATE
HYOSCYAMINE SULFATEActive
Strength: 0.1037 MG / 5 ML
Monograph: HYOSCYAMINE SULFATE
PHENOBARBITALActive
Strength: 16.2 MG / 5 ML
Monograph: PHENOBARBITAL
SCOPOLAMINE HYDROBROMIDEActive
Strength: 6.5 MCG / 5 ML
Monograph: SCOPOLAMINE HYDROBROMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.